SGMO - Sangamo Therapeutics Inc. (SGMO) CEO Sandy Macrae on Q1 2021 Results - Earnings Call Transcript

Sangamo Therapeutics, Inc. (SGMO) Q1 2021 Earnings Conference Call May 4, 2021 05:00 PM ET Company Participants Aron Feingold - Head of Corporate Communications and Investor Relations Officer Sandy Macrae - President and Chief Executive Officer Robert Schott - Senior Vice President and Head of Development Jason Fontenot - Senior Vice President and Chief Scientific Officer Mark McClung - Executive Vice President and Chief Business Officer Bettina Cockroft - Senior Vice President and Chief Medical Officer Conference Call Participants Lisa Walter - RBC Capital Markets LLC Aspen Mori - Bank of America Merrill Lynch Yanan Zhu - Wells Fargo Securities, LLC Ritu Baral - Cowen and Company, LLC Andreas Argyrides - Wedbush Securities Inc. Boran Wang - Guggenheim Securities, LLC Presentation Operator Good day, and thank you for standing by. Welcome to the Sangamo First Quarter 2021 Teleconference Call. At this time, all participants are in a listen-only mode. After

For further details see:

Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q1 2021 Results - Earnings Call Transcript